Hackensack Meridian Health Research Institute Establishes Cancer Diagnostics Company
EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.
Read MorePosted by Andy Lundin | Oct 4, 2023 | Cancer, Company News |
EValuate Diagnostics aims to make tests that detect cancer early, and will market a system for the capture of extracellular vesicles.
Read MorePosted by Andy Lundin | Oct 2, 2023 | Lung Cancer |
A novel liquid biopsy test may determine which patients with NSCLC that has spread beyond the lungs will benefit from high-dose radiation.
Read MorePosted by Andy Lundin | Sep 29, 2023 | Cancer |
Point32Health and GRAIL announced the expansion of their pilot to offer GRAIL’s Galleri multi-cancer early detection screening test.
Read MorePosted by Andy Lundin | Sep 22, 2023 | Diagnostic Technologies |
A study demonstrated clinical utility of Predicine’s MRD liquid biopsy assay in support of Genentech’s Phase 1 Clinical Trial of Divarasib.
Read MorePosted by Chris Wolski | Sep 20, 2023 | Microscopy |
Gestalt’s Mitotic Counting algorithm was trained on over 100,000 individual mitosis and across seven scanner models.
Read More